Global Digital Therapeutics Market to Reach $835.8 Million by 2024

SAN FRANCISCO, Aug. 10, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Digital Therapeutics - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 7; Released: May 2021
Executive Pool: 6337
Companies: 56 - Players covered include Canary Health, Inc.; Dthera Sciences; Fitbit Health Solutions; Livongo Health, Inc.; Medtronic, Plc; Omada Health, Inc.; Propeller Health; Pear Therapeutics, Inc.; Proteus Digital Health, Inc.; WellDoc, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Application (Preventive, Treatment/Care); Sales Channel (B2C, B2B)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Digital Therapeutics Market to Reach $835.8 Million by 2024
Digital therapeutics (DTx), an emerging trend in the rapidly growing mobile health (mHealth) space comprises software programs that blend medical intervention with digital platforms for treatment of medical disorder or conditions. Digital therapeutics enables improved health monitoring, prevention and management leading to improved health outcomes and reduced healthcare expenditure. With rising penetration of smartphones and internet usage, digital therapeutics can offer basic medical guidance, work in combination with drug regimens, use cognitive stimulation to induce behavioural chages, connect with wearables and medical equipment through the use of mobile apps. Amid the COVID-19 crisis, the global market for Digital Therapeutics is projected to reach US$835.8 Million by 2024, registering a compounded annual growth rate (CAGR) of 26.9% over the analysis period. United States represents the largest regional market for Digital Therapeutics, accounting for an estimated 65.1% share of the global total. The market is projected to reach US$708.8 Million by the close of the analysis period. United States is also forecast to emerge as the fastest growing regional market with a CAGR of 27.8% over the analysis period.

Rising incidences of chronic diseases, growing geriatric population, technological advancements, benefits of digital therapeutics, and pressing need to curb rising healthcare costs are key growth drivers spurring significant growth in global digital therapeutics market. Growth in the global market is set to be driven by strong adoption of digital platforms like smartphones, apps, electronic wearables, mobile internet; growing focus on value based care; and rising venture capital investments in digital health based business models. Proliferation of telemedicine platforms and digital healthcare tools such as mobile apps and wearables, has laid a strong foundation for evolution and growth of DTx. The momentum is likely to accelerate further with advent of next-generation technologies such as IoT and Artificial Intelligence (AI), as these 'high-tech' modalities hold immense potential to augment roll out of DTx interventions as a complementary product or as a complete replacement to traditional therapeutics. The United States and Europe represent key markets, led supported by well-developed digital infrastructure that provides the foundation for DTx. In Asia-Pacific region, growth is driven by rising prevalence of chronic illnesses and growing geriatric population.

The market for preventive application is forecast to grow the fastest over the analysis period, due to rising government initiatives to enhance preventive healthcare. Government-sponsored programs are mainly intended to encourage healthy lifestyle through broad-based self-management and patient education campaigns. Despite holding immense potential, DTx market suffers from limitations such as resistance from conventional healthcare providers, low awareness levels, patient reluctance to adopt digital therapeutics, stringent regulatory scenario, and concerns over patient data privacy. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/global-digital-therapeutics-market-to-reach-835-8-million-by-2024--301350887.html

SOURCE Global Industry Analysts, Inc.

[ Back To TMCnet.com's Homepage ]